Picture of Bio-Works Technologies AB logo

BIOWKS Bio-Works Technologies AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Bio-Works Technologies AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-44.7-9.84-46.1-56.3-38
Depreciation
Non-Cash Items-0.3930.4181.0800.125
Other Non-Cash Items
Changes in Working Capital1.32-4.74.67-3.25-5.81
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-43.4-13.4-39.9-59-43.2
Capital Expenditures-0.326-0.942-1.12-0.86-0.008
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.166
Sale of Fixed Assets
Cash from Investing Activities-0.326-0.942-1.12-0.860.158
Financing Cash Flow Items-2.71-0.132-0.027-1.23
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities0.348844.0433.337.8
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-43.369.7-36.9-26.5-5.1